Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) SHH
9.92
-0.05999992(-0.60%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
9.92
-0.05999992(-0.60%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8062
First IPO Date
July 25, 2000
| Name | Title | Pay | Year Born |
| Weihong Xiao | Chief Executive Officer & Chairman | 0 | 1969 |
| Hong Shun Jin | Senior Vice President | 0 | 1976 |
| Zhiqing Yang | Senior Vice President | 0 | 1975 |
| Jiaqiu Du | Senior Vice President & Director | 0 | 1974 |
| Ling Jiang | Senior Vice President, Accounting Supervisor & Chief Financial Officer | 0 | 1971 |
| Xi Fei Shen | Secretary of the Board | 0 | 1973 |
Zhejiang Hisun Pharmaceutical Co., Ltd. manufactures and supplies pharmaceutical products in China. It provides active pharmaceutical ingredients and finished dosage form products. The company offers products in the areas of anti-tumor, cardiovascular, anti-infective, liver care, orthopedics, anticancer, anti-parasitic, immunosuppressant, etc.; and weight loss, anti-viral, anti-TB, veterinary pharma, and others. It also provides product consultation and CMO/CRO manufacturing services. The company was founded in 1956 and is headquartered in Taizhou, China.